Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years’ experiences (Q35126829)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 1, 2003

Language	Label	Description	Also known as
English	Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years’ experiences	scientific article published on May 1, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years' experiences (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Treatment and re-treatment strategies for schistosomiasis control in different epidemiological settings: a review of 10 years’ experiences (English)

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

schistosomiasis

0 references

Pascal Magnussen

1

object named as

Pascal Magnussen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12745141

2 January 2024

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0001706X03000457?httpAccept=text/xml

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

https://api.elsevier.com/content/article/PII:S0001706X03000457?httpAccept=text/plain

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

243-254

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Schistosomiasis in the Republic of São Tomé and Principe: human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Alternative approaches in schistosomiasis control

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Ultrasonographical assessment of morbidity in schistosomiasis mansoni in Madagascar: a community-based study in a rural population

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Planning chemotherapy based schistosomiasis control: validation of a mathematical model using data on Schistosoma haematobium from Pemba, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Chemotherapy of schistosomiasis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Control of schistosomiasis in Brazil: perspectives and proposals

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

The relationship between Schistosoma haematobium infection and school performance and attendance in Bamako, Mali.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Praziquantel and the control of schistosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Control of Schistosoma mansoni and intestinal helminths: 8-year follow-up of an urban school programme in Bujumbura, Burundi

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Increase of intestinal schistosomiasis after praziquantel treatment in a Schistosoma haematobium and Schistosoma mansoni mixed focus

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

The morbidity of schistosomiasis mansoni in Maniema (Zaire).

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Morbidity, due to schistosomiasis mansoni, and its control in Subsaharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Repeated community-based chemotherapy for the control of Schistosoma mansoni: effect of screening and selective treatment on prevalences and intensities of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Schistosomiasis control in China

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

The 1992-1999 World Bank Schistosomiasis Research Initiative in China: outcome and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. I. Parasitological effects and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Repeated mass treatment of schistosomiasis mansoni: experience in hyperendemic areas of Brazil. 3. Techniques for assessment and surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Community-based questionnaires and health statistics as tools for the cost-efficient identification of communities at risk of urinary schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Simple school questionnaires can map both Schistosoma mansoni and Schistosoma haematobium in the Democratic Republic of Congo

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Epidemiology of Schistosoma japonicum in China: morbidity and strategies for control in the Dongting Lake region

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

The relationship between prevalence of Schistosoma haematobium infection and different morbidity indicators during the course of a control programme on Pemba Island

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

A school-based approach to the control of urinary schistosomiasis and intestinal helminth infections in children in Matuga, Kenya: impact of a two-year chemotherapy programme on prevalence and intensity of infections

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

The impact of a school health programme on the prevalence and morbidity of urinary schistosomiasis in Mwera Division, Pangani District, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Sensitivity, specificity and positive predictive value of selected clinical signs and symptoms associated with schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Five year impact of chemotherapy on morbidity attributable to Schistosoma japonicum infection in the Dongting Lake region

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Control of schistosomiasis--a global picture

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Observations on the effects of different chemotherapy strategies on the transmission of Schistosoma mansoni in Machakos District, Kenya, measured by long-term snail sampling and cercariometry

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

The potential of artemether for the control of schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Assessment of morbidity in Schistosoma haematobium infection: current methods and future tools

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Resolution and resurgence of schistosoma haematobium-induced pathology after community-based chemotherapy in ghana, as detected by ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Progress in the control of schistosomiasis in Egypt 1985-1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Diagnosis of schistosomiasis japonica in Chinese schoolchildren by administration of a questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Some personal views on the control of schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2803%2900045-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: lessons from the practice

1

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

Selective population chemotherapy among schoolchildren in Beheira governorate: the UNICEF/Arab Republic of Egypt/WHO Schistosomiasis Control Project

17

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

Schistosomiasis mansoni in Burundi: progress in its control since 1985

18

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

Morbidity due to infection with Schistosoma mansoni: an update

22

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

The use of questionnaires for the identification of communities at risk for intestinal schistosomiasis in western Gojam

26

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

Control of Schistosoma haematobium morbidity on Pemba Island: validity and efficiency of indirect screening tests

42

1 reference

10.1016/S0001-706X(03)00045-7

https://api.crossref.org/works/10.1016/S0001-706X(03)00045-7

2 January 2024

Identifiers

10.1016/S0001-706X(03)00045-7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35126829&oldid=2042993097"